C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2006
11/23/2006	WO2006039253A3 Sirna-mediated gene silencing of alpha synuclein
11/23/2006	WO2006024880A3 Methods and compositions to inhibit p2x7 receptor expression
11/23/2006	WO2006020480A3 Adenoviral vector compositions
11/23/2006	WO2006016097A3 Vector comprising polymer modified sirna liposomes
11/23/2006	WO2005121778A3 Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases
11/23/2006	WO2005118825A3 Chimeric adenoviruses for use in cancer treatment
11/23/2006	WO2005113781A3 Vectors for use in gene and cancer therapy
11/23/2006	WO2005074995A3 Combined use of prame inhibitors and hdac inhibitors
11/23/2006	WO2005038002A3 Site-specific incorporation of redox active amino acids into proteins
11/23/2006	US20060265788 Plant-specific genetic elements and transfer cassettes for plant transformation
11/23/2006	US20060265787 Recombinant carrier molecule for expression, delivery and purification of target polypeptides
11/23/2006	US20060265786 Counter selection strategy for Gram-negative bacteria
11/23/2006	US20060265785 Isolated polynucleotide having a nucleotide sequence encoding a polypeptide with 1-deoxy-D-xylulose 5-phosphate reductoisomerase activity
11/23/2006	US20060265784 Tagetes erecta MARIGOLDS WITH ALTERED CAROTENOID COMPOSITIONS AND RATIOS
11/23/2006	US20060265783 growth modulators; modifying RKS genes or gene products as found in Arabidopsis thaliana or other plants; method for increasing organ size or rate of cell division of a plant or plant cell
11/23/2006	US20060265782 Novel plant transcribed regions and uses thereof
11/23/2006	US20060265781 Novel Rubisco promoters and uses thereof
11/23/2006	US20060265780 Interaction of glyphosate with photosystem II inhibitor herbicides as a selection tool for roundup ready events
11/23/2006	US20060265779 Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases for the conference of drug resistance and for the loss of drug resistance in biological systems and methods for the detection of ecto-phosphatase inhibitors
11/23/2006	US20060265778 Plants and seeds of corn variety ex6077
11/23/2006	US20060265777 Regulatory regions from Papaveraceae
11/23/2006	US20060265776 Viability
11/23/2006	US20060265775 Method for generating plant diversity by incorporation of microsatellite sequences into the plant genome
11/23/2006	US20060265773 Methods for producing transgenic animals with modified disease resistance
11/23/2006	US20060265772 Histamine hyperproductive animal
11/23/2006	US20060265769 Gab2 (p97) gene and methods of use thereof
11/23/2006	US20060265765 Oncogene HOXB13 and its siRNAs
11/23/2006	US20060265763 Dyrks as modifiersof the apc and axin pathways and methods of use
11/23/2006	US20060264615 Which induce proliferation of lymphocytes in presence of wild-type p35 polypeptide subunit of human interleukin-12; site directed mutagenesis
11/23/2006	US20060264612 Optimised protein synthesis
11/23/2006	US20060264610 Protein complexes of the tip60 transcriptional activator protein
11/23/2006	US20060264609 Use of heat shock proteins
11/23/2006	US20060264603 treating edema with Kallikrein inhibitor; bovine pancreatic trypsin inhibitor mutants; possibly ecallantide
11/23/2006	US20060264395 Modulation of apolipoprotein c-III expression
11/23/2006	US20060264394 Livin-specific sirnas for the treatment of therapy-resistant tumors
11/23/2006	US20060264393 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases
11/23/2006	US20060264392 Modulators of angiogenesis
11/23/2006	US20060264370 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith
11/23/2006	US20060264363 Inhibition of nerve cell death by inhibiting degradation of shc3, atf6 or crebl1 by htra2 and method of ameliorating neurodegenerative diseases
11/23/2006	US20060264361 Novel lysophosphatidic acid receptor
11/23/2006	US20060263883 Recombinant herpes viruses for preparing recombinant adeno-associated viruses
11/23/2006	US20060263882 Multi-cistronic vectors for gene transfer protocols
11/23/2006	US20060263871 Nucleic acid applification reaction station for disposable test devices
11/23/2006	US20060263868 Rhodococcus - E. coli shuttle vector
11/23/2006	US20060263867 Delta-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts
11/23/2006	US20060263866 Delta-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts
11/23/2006	US20060263864 Methods for improving secondary metabolite production of fungi
11/23/2006	US20060263863 Manipulation of genes of the mevalonate and isoprenoid pathways to create novel traits in transgenic organisms
11/23/2006	US20060263862 Preparing vitamin B6 by culturing vitamin b6 phosphate using the recombinant microorganisms (Escherichia) or the polypeptide
11/23/2006	US20060263861 Method for producing beta-hydroxy amino acid and enzyme used therefor
11/23/2006	US20060263858 Hyaluronan synthase genes and expression thereof in Bacillus hosts
11/23/2006	US20060263856 Expression technology for proteins containing a hybrid isotype antibody moiety
11/23/2006	US20060263855 Intein-mediated protein purification using in vivo expression of an elastin-like protein
11/23/2006	US20060263854 Immunodiagnostic assays using reducing agents
11/23/2006	US20060263852 Asp2
11/23/2006	US20060263838 Soluble pyrroloquinoline quinone; culturing microorganisms; thermal stability
11/23/2006	US20060263831 Interfacial biomaterials for binding ceramic substrates
11/23/2006	US20060263830 Interfacial biomaterials
11/23/2006	US20060263820 Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins
11/23/2006	US20060263819 Diagnostics and therapeutics for macular degeneration-related disorders
11/23/2006	US20060263794 Methods for detecting target nucleic acids using coupled ligation and amplification
11/23/2006	US20060263785 Detection of aneuploidy
11/23/2006	US20060263784 Method for the diagnosis/prognosis of neuroblastoma
11/23/2006	US20060263781 Regulation of cell surface proteins
11/23/2006	US20060263778 Animals with reduced body fat and increased bone density
11/23/2006	US20060263776 Serine protease
11/23/2006	US20060263774 Nucleotide sequences, vectors, transformed host cells, polypeptides, antibodies; monocyte/macrophage mediated disorders
11/23/2006	US20060263770 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
11/23/2006	US20060263768 Matrix screening method
11/23/2006	US20060263764 Methods and constructs for evaluation of rnai targets and effector molecules
11/23/2006	US20060263435 nucleic acid such as siRNAs; carrier includes a cyclodextrin polymer; treatment of cell proliferative disorders, such as cancer or pathogen infections
11/23/2006	US20060263432 Polyhydroxyalkanoate-containing magnetic structure, and manufacturing method and use thereof
11/23/2006	US20060263422 Pharmaceutical composition containing decoy and use of the same
11/23/2006	US20060263391 Process for the preparation of hypoallergenic mosaic antigens
11/23/2006	US20060263387 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus
11/23/2006	US20060263383 Prognostic indicator
11/23/2006	US20060263381 Peptide epitopes common to antigens of the same multigene family
11/23/2006	US20060263371 Prognostic indicator
11/23/2006	US20060263370 Prognostic indicator
11/23/2006	US20060263369 Administering an antibody that selectively binds to the extracellular region of human magic roundabout (MR); inhibiting angiogenesis
11/23/2006	US20060263334 Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen
11/23/2006	US20060263303 Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use
11/23/2006	DE10344545B9 Genetisch modifiziertes Kapsidprotein des Beak and Feather Disease Virus Genetically modified capsid protein of the Beak and Feather Disease Virus
11/23/2006	DE102006024359A1 Preparing an animal model for the human immune system, useful e.g. for preparation of human antibodies and as an experimental model for disease, comprises animal containing transplanted human stem cells
11/23/2006	DE102005023993A1 Nicht virales Vektorsystem zum Transport von Nukleinsäure in die Lunge Non-viral vector system for transporting nucleic acid into the lungs
11/23/2006	DE102005023761A1 An die Lck-SH3 und Hck-SH3 Domäne bindende Peptide At the Lck-SH3 and SH3 domain binding peptides Hck
11/23/2006	DE102005022146A1 Isoliertes Photoprotein AQdecay sowie dessen Verwendung An isolated photo AQdecay and its use
11/23/2006	CA2625583A1 Corn plants and seed enhanced for asparagine and protein
11/23/2006	CA2609814A1 Method for amelioration of disease condition induced by mood disorder
11/23/2006	CA2609150A1 Compositions, methods and kits for real-time nucleic acid analysis in live cells
11/23/2006	CA2609102A1 Int6 protein involved in hypoxia stress induction and use thereof
11/23/2006	CA2609067A1 An oligonucleotide or its functional homologue, a composition comprising the same and a method for treating b cell neoplasm
11/23/2006	CA2609062A1 Oligonucleotides or their functional homologues, a composition comprising the same and a method of treating b cell neoplasm
11/23/2006	CA2609043A1 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections
11/23/2006	CA2608792A1 High molecular compound for medical material, and biochip substrate using such high molecular compound
11/23/2006	CA2608764A1 Treatment of disease using an improved regulated expression system
11/23/2006	CA2608742A1 Dna fragments, primers, kits, and methods for amplification the detection and identification of clinically relevant candida species
11/23/2006	CA2608717A1 Resistance to soybean aphid in early maturing soybean germplasm
11/23/2006	CA2608712A1 Endothelized artificial matrix comprising a fibrin gel, which is a superproducer of proangiogenic factors
11/23/2006	CA2608656A1 Regulated vectors for selection of cells exhibiting desired phenotypes

1 ... 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 ... 4023